… focused on different aspects of the regulation of immune checkpoints in the TME (tumor
microenvironment), including regulation … intestinal flora and mutual regulation by various immune …

… and clinical benefits in patients with cancer at late stages. Most studies … how ICIs may target
Tregs for cancer immunotherapy. … In this review, we focus on the impact of inhibitors against …

… , we primarily focus on summarizing PD-L1 regulation and its potential roles in regulating
antitumor … to optimize anti-PD-1/PD-L1 therapies, benefiting a wider cancer patient population. …

… effects of T H cells, with an emphasis on regulation of different T H cell subtypes by various
… influence overall success of cancer immunotherapy. We focus on the regulatory network that …

… to reduce regulatory cells in cancer … regulatory cells in cancer patients. Some approaches
aim to reduce the frequency, function and extent of blocking mobilization, while others focus on …

… , and to be able to use regulatory T cells for tumor immunotherapy more quickly. This review
focuses on the research progress of various mechanisms of regulatory T cells in the tumor …

… also can be predictive for response to contemporary cancer immunotherapies. The generation
of a … that can respond to immunotherapies, such as with checkpoint blockade antibodies. …

… This review focuses on our current understanding of the roles of FOXP3 + Treg cells in
tumor … or functional manipulation of Treg cells as a key strategy in cancer immunotherapy. …

… in focus MicroRNAs in immune regulation—Opportunities for cancer immunotherapy☆ …
overcome some of our current challenges in cancer immunotherapy. Continued basic studies and …

… Thus, both cancer cells and other regulatory immune cells release inhibitory cytokines and …
PD1/PDL1 immunotherapy. Until recently, the main focus of cancer immunotherapy has been …